BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15960361)

  • 21. [Hürthle cells carcinoma. Report of two operated cases and review of the literature].
    Pino Rivero V; González Palomino A; Trinidad Ruíz G; Keituqwa Yáñez T; Marcos García M; Pardo Romero G; Pantoja Hernández CG; Blasco Huelva A
    An Otorrinolaringol Ibero Am; 2005; 32(5):467-73. PubMed ID: 16318090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hürthle cell carcinoma: a clinicopathological study of thirteen cases.
    Ozlem Küçük N; Kulak H; Tokmak E; Tar P; Ibiş E; Aras G
    Nucl Med Commun; 2006 Apr; 27(4):377-9. PubMed ID: 16531925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fine-needle aspiration biopsy of Hurthle cell lesions of the thyroid gland: A cytomorphologic study of 139 cases with statistical analysis.
    Elliott DD; Pitman MB; Bloom L; Faquin WC
    Cancer; 2006 Apr; 108(2):102-9. PubMed ID: 16453320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hürthle cell carcinoma of the thyroid. A 41 years experience].
    Sanz J; Cerpa F; Domínguez M; Franco C; Jadresic A; Pérez G; Phillipi V
    Rev Med Chil; 1999 Jul; 127(7):821-6. PubMed ID: 10668290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hurthle cell thyroid tumor: an analysis of 28 cases].
    Yang XY; Hu CX; Yang LZ; Zhao WC; Pan Y
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Nov; 45(11):908-11. PubMed ID: 21215204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fine-needle aspiration biopsies in the management of indeterminate follicular and Hurthle cell thyroid lesions.
    Mijović T; Rochon L; Gologan O; Hier MP; Black MJ; Young J; Payne RJ
    Otolaryngol Head Neck Surg; 2009 May; 140(5):715-9. PubMed ID: 19393417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Report of a hürthle cell neoplasm in a peripubertal girl.
    Bremer AA; Feldman BJ; Iezza G; Clark OH; Rosenthal SM
    Thyroid; 2007 Feb; 17(2):175-8. PubMed ID: 17316121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hurthle cell neoplasm of the thyroid gland.
    Ahmed M; Bin Yousef H; Greer W; Faraz H; Al Sobhi S; Al Zahrani A; Raef H; Al Ghamdi A; Al Kadhi Y; Al Dayel F
    ANZ J Surg; 2008 Mar; 78(3):139-43. PubMed ID: 18269475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Thyroidal oxyphilic tumors].
    Sabo R; Zohar Y; Schwartz A; Segal K
    Harefuah; 1994 Feb; 126(4):183-6, 240. PubMed ID: 8168757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hurthle cell neoplasm of the thyroid gland.
    Sidhu S
    ANZ J Surg; 2008 Mar; 78(3):115. PubMed ID: 18269467
    [No Abstract]   [Full Text] [Related]  

  • 31. [Large-cell eosinophilic tumors of the thyroid gland].
    Krayenbühl JC; Hedinger C
    Schweiz Med Wochenschr; 1985 Apr; 115(15):512-22. PubMed ID: 3992235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hürthle cell tumors.
    Hillman N; Hardisson D; Herranz L; Martinez Olmos MA; Hernandez Bayo JA; Nistal M; Pallardo LF
    Ann Med Interne (Paris); 1997; 148(6):434-9. PubMed ID: 9538377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid.
    Máximo V; Preto A; Crespo A; Rocha AS; Machado JC; Soares P; Sobrinho-Simões M
    BMC Cancer; 2004 Mar; 4():12. PubMed ID: 15043758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Thyroid oncocytomas].
    Oueslati Z; Ben-Assouna H; Touati S; Gritli S; el-May A; Gamoudi A; Benna F; Ladgham A
    Rev Laryngol Otol Rhinol (Bord); 2002; 123(4):235-8. PubMed ID: 12723488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors of recurrence in encapsulated Hurthle cell carcinoma of the thyroid gland: a clinicopathologic study of 50 cases.
    Ghossein RA; Hiltzik DH; Carlson DL; Patel S; Shaha A; Shah JP; Tuttle RM; Singh B
    Cancer; 2006 Apr; 106(8):1669-76. PubMed ID: 16534796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgery for thyroid Hürthle cell tumours--a single institution experience.
    Paunovic I; Krgovic K; Tatic S; Diklic A; Zivaljevic V; Kalezic N; Havelka M
    Eur J Surg Oncol; 2006 May; 32(4):458-61. PubMed ID: 16497473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemithyroidectomy: the preferred initial surgical approach for management of Hurthle cell neoplasm.
    Melck A; Bugis S; Baliski C; Irvine R; Anderson DW; Wilkins G; Zhang H; Wiseman SM
    Am J Surg; 2006 May; 191(5):593-7. PubMed ID: 16647343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hürthle cell neoplasm.
    Marzano LA; Finelli L; Marranzini A; Lupoli G; La Manna S; Zarrilli S; Zarrilli L
    Int Surg; 1989; 74(2):97-8. PubMed ID: 2753630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Differential diagnosis of oxyphilic (Hürthle cell) adenomas and carcinomas of the thyroid].
    Tret'iakova MS; Bussolati J
    Arkh Patol; 2000; 62(6):14-8. PubMed ID: 11198115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hürthle cell carcinoma is a better gold standard than Hürthle cell neoplasm for fine-needle aspiration of the thyroid: defining more consistent and specific cytologic criteria.
    Renshaw AA
    Cancer; 2002 Oct; 96(5):261-6. PubMed ID: 12378592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.